September 18, 2019 / 9:41 PM / a month ago

Boehringer says preemption ruling warrants tossing Pradaxa cases

Boehringer Ingelheim has asked a Connecticut judge to dismiss thousands of lawsuits alleging its blood thinner Pradaxa’s label did not adequately warn of bleeding risks, saying the plaintiffs agree a recent ruling could doom the “vast majority” of cases.

The drugmaker laid out its position in a brief on Tuesday, nearly a week after a judge in Hartford found that some of the state-law warning claims asserted by a New York man at trial were preempted by federal law. The judge however declined to overturn the verdict in his favor against the company.

To read the full story on WestlawNext Practitioner Insights, click here:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below